Literature DB >> 24776334

Epidemiology of heart failure in Spain over the last 20 years.

Inés Sayago-Silva1, Fernando García-López2, Javier Segovia-Cubero3.   

Abstract

Heart failure is a major health care problem in Spain, although its precise impact is unknown due to the lack of data from appropriately designed studies. In contrast with the 2% prevalence of heart failure elsewhere in Europe and in the United States, studies in Spain report figures of 5%, probably because of methodological limitations. Heart failure consumes enormous quantities of health care resources; it is the first cause of hospitalization in persons aged 65 years or older and represents 3% of all hospital admissions and 2.5% of health care costs. There are two patterns of heart failure: one with preserved systolic function, more often associated with high blood pressure, and another with depressed systolic function, more often associated with ischemic heart disease. In 2010, heart failure accounted for 3% of all deaths in men and for 10% of all deaths in women. In recent years, the mortality rate from heart failure has gradually fallen. The rise in hospital admissions for heart failure and the decrease in mortality from this cause could partly be explained by temporary changes in diagnostic coding, but there is evidence that the reduced mortality could also be due to adherence to clinical practice guidelines.
Copyright © 2013 Sociedad Española de Cardiología. Published by Elsevier Espana. All rights reserved.

Entities:  

Keywords:  Epidemiology; Epidemiología; España; HF; Heart failure; Insuficiencia cardiaca; PC; Spain; heart failure; primary care

Mesh:

Year:  2013        PMID: 24776334     DOI: 10.1016/j.rec.2013.03.012

Source DB:  PubMed          Journal:  Rev Esp Cardiol (Engl Ed)        ISSN: 1885-5857


  25 in total

1.  Patient-Associated Predictors of 15- and 30-Day Readmission After Hospitalization for Acute Heart Failure.

Authors:  Juan F Delgado; Andreu Ferrero Gregori; Laura Morán Fernández; Ramón Bascompte Claret; Andrés Grau Sepúlveda; Francisco Fernández-Avilés; José R González-Juanatey; Rafael Vázquez García; Miguel Rivera Otero; Javier Segovia Cubero; Domingo Pascual Figal; Maria G Crespo-Leiro; Jesús Alvarez-García; Juan Cinca; Fernando Arribas Ynsaurriaga
Journal:  Curr Heart Fail Rep       Date:  2019-12

Review 2.  GLP-1 Receptor Agonists and Cardiovascular Disease in Patients with Type 2 Diabetes.

Authors:  María Isabel Del Olmo-Garcia; Juan Francisco Merino-Torres
Journal:  J Diabetes Res       Date:  2018-04-02       Impact factor: 4.011

3.  Impact of a pharmaceutical care programme for patients with chronic disease initiated at the emergency department on drug-related negative outcomes: a randomised controlled trial.

Authors:  Ana Juanes; Noe Garin; Maria Antonia Mangues; Sergio Herrera; Mireia Puig; Maria Jose Faus; Maria Isabel Baena
Journal:  Eur J Hosp Pharm       Date:  2017-02-23

4.  Management of suspected acute heart failure dyspnea in the emergency department: results from the French prospective multicenter DeFSSICA survey.

Authors:  Tahar Chouihed; Stéphane Manzo-Silberman; Nicolas Peschanski; Sandrine Charpentier; Meyer Elbaz; Dominique Savary; Eric Bonnefoy-Cudraz; Said Laribi; Patrick Henry; Nicolas Girerd; Faiez Zannad; Carlos El Khoury
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2016-09-17       Impact factor: 2.953

5.  Patients with HFpEF and HFrEF have different clinical characteristics but similar prognosis: a retrospective cohort study.

Authors:  Tamrat Befekadu Abebe; Eyob Alemayehu Gebreyohannes; Yonas Getaye Tefera; Tadesse Melaku Abegaz
Journal:  BMC Cardiovasc Disord       Date:  2016-11-21       Impact factor: 2.298

6.  Self-Care Practices of Primary Health Care Patients Diagnosed with Chronic Heart Failure: A Cross-Sectional Survey.

Authors:  Rosalia Santesmases-Masana; Luis González-de Paz; Elvira Hernández-Martínez-Esparza; Belchin Kostov; Maria Dolors Navarro-Rubio
Journal:  Int J Environ Res Public Health       Date:  2019-05-09       Impact factor: 3.390

7.  [Clinical characteristics and risk factors for mortality upon admission in patients with heart failure hospitalized due to COVID-19 in Spain].

Authors:  A Salinas-Botrán; J Sanz-Cánovas; J Pérez-Somarriba; L M Pérez-Belmonte; L Cobos-Palacios; M Rubio-Rivas; S de-Cossío-Tejido; J M Ramos-Rincón; M Méndez-Bailón; R Gómez-Huelgas
Journal:  Rev Clin Esp       Date:  2021-07-17       Impact factor: 3.064

8.  Examination of the potential association of stress with morbidity and mortality outcomes in patient with heart failure.

Authors:  Abdullah S Alhurani; Rebecca Dekker; Elizabeth Tovar; Alison Bailey; Terry A Lennie; David C Randall; Debra K Moser
Journal:  SAGE Open Med       Date:  2014-12

Review 9.  Design of a multicentre randomized controlled trial to assess the safety and efficacy of dose titration by specialized nurses in patients with heart failure. ETIFIC study protocol.

Authors:  Juana Oyanguren; LLuisa García-Garrido; Magdalena Nebot Margalef; Iñaki Lekuona; Josep Comin-Colet; Nicolás Manito; Julia Roure; Pilar Ruiz Rodriguez; Cristina Enjuanes; Pedro Latorre; Jesús Torcal Laguna; Susana García-Gutiérrez
Journal:  ESC Heart Fail       Date:  2017-04-03

10.  Outcomes following heart failure hospitalization in a regional Australian setting between 2005 and 2014.

Authors:  Mohammed S Al-Omary; Arshad A Khan; Allan J Davies; Peter J Fletcher; Dawn Mcivor; Bruce Bastian; Christopher Oldmeadow; Aaron L Sverdlov; John R Attia; Andrew J Boyle
Journal:  ESC Heart Fail       Date:  2017-12-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.